nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—SLC15A2—choroid plexus—brain cancer	0.0882	0.644	CbGeAlD
Ceftibuten—Nephropathy toxic—Lomustine—brain cancer	0.0398	0.0462	CcSEcCtD
Ceftibuten—Digestion impaired—Hydroxyurea—brain cancer	0.0168	0.0195	CcSEcCtD
Ceftibuten—Nephropathy toxic—Carmustine—brain cancer	0.0158	0.0183	CcSEcCtD
Ceftibuten—Melaena—Procarbazine—brain cancer	0.0142	0.0164	CcSEcCtD
Ceftibuten—Aphasia—Carmustine—brain cancer	0.014	0.0162	CcSEcCtD
Ceftibuten—Pancytopenia—Lomustine—brain cancer	0.0136	0.0158	CcSEcCtD
Ceftibuten—Aphasia—Temozolomide—brain cancer	0.0135	0.0157	CcSEcCtD
Ceftibuten—Digestion impaired—Temozolomide—brain cancer	0.0131	0.0152	CcSEcCtD
Ceftibuten—Renal failure—Lomustine—brain cancer	0.0126	0.0146	CcSEcCtD
Ceftibuten—Nephropathy toxic—Etoposide—brain cancer	0.0122	0.0142	CcSEcCtD
Ceftibuten—Haemolytic anaemia—Procarbazine—brain cancer	0.0117	0.0135	CcSEcCtD
Ceftibuten—Cholestasis—Temozolomide—brain cancer	0.0116	0.0134	CcSEcCtD
Ceftibuten—Haemoglobin—Lomustine—brain cancer	0.0115	0.0134	CcSEcCtD
Ceftibuten—Haemorrhage—Lomustine—brain cancer	0.0115	0.0133	CcSEcCtD
Ceftibuten—Rigors—Temozolomide—brain cancer	0.0108	0.0125	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00949	0.011	CcSEcCtD
Ceftibuten—Vaginal inflammation—Temozolomide—brain cancer	0.00878	0.0102	CcSEcCtD
Ceftibuten—Candida infection—Carmustine—brain cancer	0.00868	0.0101	CcSEcCtD
Ceftibuten—Pancytopenia—Procarbazine—brain cancer	0.00865	0.01	CcSEcCtD
Ceftibuten—Rigors—Etoposide—brain cancer	0.00861	0.00997	CcSEcCtD
Ceftibuten—Candida infection—Temozolomide—brain cancer	0.00838	0.00971	CcSEcCtD
Ceftibuten—Vaginal infection—Temozolomide—brain cancer	0.00829	0.00961	CcSEcCtD
Ceftibuten—Aplastic anaemia—Temozolomide—brain cancer	0.00824	0.00955	CcSEcCtD
Ceftibuten—Jaundice—Procarbazine—brain cancer	0.00792	0.00918	CcSEcCtD
Ceftibuten—Anorexia—Lomustine—brain cancer	0.00778	0.00901	CcSEcCtD
Ceftibuten—Haematuria—Procarbazine—brain cancer	0.00775	0.00898	CcSEcCtD
Ceftibuten—Body temperature increased—Carboplatin—brain cancer	0.00737	0.00854	CcSEcCtD
Ceftibuten—Haemoglobin—Procarbazine—brain cancer	0.00733	0.00849	CcSEcCtD
Ceftibuten—Haemorrhage—Procarbazine—brain cancer	0.00729	0.00845	CcSEcCtD
Ceftibuten—Decreased appetite—Lomustine—brain cancer	0.0071	0.00822	CcSEcCtD
Ceftibuten—Nasal congestion—Temozolomide—brain cancer	0.007	0.00811	CcSEcCtD
Ceftibuten—Candida infection—Etoposide—brain cancer	0.00671	0.00777	CcSEcCtD
Ceftibuten—Pancytopenia—Hydroxyurea—brain cancer	0.0067	0.00776	CcSEcCtD
Ceftibuten—Dysuria—Hydroxyurea—brain cancer	0.00659	0.00764	CcSEcCtD
Ceftibuten—Neutropenia—Hydroxyurea—brain cancer	0.00659	0.00764	CcSEcCtD
Ceftibuten—Chills—Procarbazine—brain cancer	0.00654	0.00758	CcSEcCtD
Ceftibuten—Body temperature increased—Lomustine—brain cancer	0.00645	0.00748	CcSEcCtD
Ceftibuten—SLC15A1—endocrine gland—brain cancer	0.00626	0.0457	CbGeAlD
Ceftibuten—SLC15A2—telencephalon—brain cancer	0.0062	0.0453	CbGeAlD
Ceftibuten—Dehydration—Temozolomide—brain cancer	0.00593	0.00687	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00574	0.00665	CcSEcCtD
Ceftibuten—Haemoglobin—Hydroxyurea—brain cancer	0.00567	0.00657	CcSEcCtD
Ceftibuten—Haemorrhage—Hydroxyurea—brain cancer	0.00564	0.00654	CcSEcCtD
Ceftibuten—Convulsion—Procarbazine—brain cancer	0.0055	0.00637	CcSEcCtD
Ceftibuten—Pancytopenia—Carmustine—brain cancer	0.00541	0.00627	CcSEcCtD
Ceftibuten—Neutropenia—Carmustine—brain cancer	0.00533	0.00618	CcSEcCtD
Ceftibuten—Dry mouth—Procarbazine—brain cancer	0.00529	0.00613	CcSEcCtD
Ceftibuten—Pancytopenia—Temozolomide—brain cancer	0.00523	0.00606	CcSEcCtD
Ceftibuten—Vomiting—Lomustine—brain cancer	0.00519	0.00601	CcSEcCtD
Ceftibuten—Neutropenia—Temozolomide—brain cancer	0.00515	0.00597	CcSEcCtD
Ceftibuten—Dysuria—Temozolomide—brain cancer	0.00515	0.00597	CcSEcCtD
Ceftibuten—Chills—Hydroxyurea—brain cancer	0.00506	0.00587	CcSEcCtD
Ceftibuten—SLC15A2—pituitary gland—brain cancer	0.00505	0.0369	CbGeAlD
Ceftibuten—Renal failure—Carmustine—brain cancer	0.005	0.00579	CcSEcCtD
Ceftibuten—Anorexia—Procarbazine—brain cancer	0.00494	0.00572	CcSEcCtD
Ceftibuten—SLC15A2—medulla oblongata—brain cancer	0.00487	0.0356	CbGeAlD
Ceftibuten—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00487	0.00564	CcSEcCtD
Ceftibuten—Nausea—Lomustine—brain cancer	0.00485	0.00562	CcSEcCtD
Ceftibuten—Insomnia—Procarbazine—brain cancer	0.00469	0.00543	CcSEcCtD
Ceftibuten—Paraesthesia—Procarbazine—brain cancer	0.00465	0.00539	CcSEcCtD
Ceftibuten—Somnolence—Procarbazine—brain cancer	0.00461	0.00534	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00459	0.00532	CcSEcCtD
Ceftibuten—Haemoglobin—Carmustine—brain cancer	0.00459	0.00531	CcSEcCtD
Ceftibuten—Haemorrhage—Carmustine—brain cancer	0.00456	0.00529	CcSEcCtD
Ceftibuten—Decreased appetite—Procarbazine—brain cancer	0.0045	0.00522	CcSEcCtD
Ceftibuten—Fatigue—Procarbazine—brain cancer	0.00447	0.00518	CcSEcCtD
Ceftibuten—SLC15A2—midbrain—brain cancer	0.00445	0.0325	CbGeAlD
Ceftibuten—Haemoglobin—Temozolomide—brain cancer	0.00443	0.00514	CcSEcCtD
Ceftibuten—Constipation—Procarbazine—brain cancer	0.00443	0.00513	CcSEcCtD
Ceftibuten—Haemorrhage—Temozolomide—brain cancer	0.00441	0.00511	CcSEcCtD
Ceftibuten—SLC15A2—spinal cord—brain cancer	0.00434	0.0317	CbGeAlD
Ceftibuten—Convulsion—Hydroxyurea—brain cancer	0.00426	0.00493	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Procarbazine—brain cancer	0.00424	0.00491	CcSEcCtD
Ceftibuten—Pancytopenia—Etoposide—brain cancer	0.00419	0.00485	CcSEcCtD
Ceftibuten—Erythema multiforme—Temozolomide—brain cancer	0.00417	0.00483	CcSEcCtD
Ceftibuten—Neutropenia—Etoposide—brain cancer	0.00412	0.00478	CcSEcCtD
Ceftibuten—Urticaria—Procarbazine—brain cancer	0.00412	0.00477	CcSEcCtD
Ceftibuten—Abdominal pain—Procarbazine—brain cancer	0.0041	0.00475	CcSEcCtD
Ceftibuten—Body temperature increased—Procarbazine—brain cancer	0.0041	0.00475	CcSEcCtD
Ceftibuten—Chills—Temozolomide—brain cancer	0.00396	0.00458	CcSEcCtD
Ceftibuten—SLC15A2—endocrine gland—brain cancer	0.00391	0.0286	CbGeAlD
Ceftibuten—Stevens-Johnson syndrome—Etoposide—brain cancer	0.0039	0.00452	CcSEcCtD
Ceftibuten—Renal failure—Etoposide—brain cancer	0.00386	0.00448	CcSEcCtD
Ceftibuten—SLC15A2—head—brain cancer	0.00386	0.0282	CbGeAlD
Ceftibuten—Jaundice—Etoposide—brain cancer	0.00383	0.00444	CcSEcCtD
Ceftibuten—Anorexia—Hydroxyurea—brain cancer	0.00382	0.00443	CcSEcCtD
Ceftibuten—Hypersensitivity—Procarbazine—brain cancer	0.00382	0.00442	CcSEcCtD
Ceftibuten—Dysgeusia—Temozolomide—brain cancer	0.00376	0.00436	CcSEcCtD
Ceftibuten—Asthenia—Procarbazine—brain cancer	0.00372	0.00431	CcSEcCtD
Ceftibuten—Agranulocytosis—Etoposide—brain cancer	0.00367	0.00425	CcSEcCtD
Ceftibuten—Pruritus—Procarbazine—brain cancer	0.00367	0.00425	CcSEcCtD
Ceftibuten—Agitation—Carmustine—brain cancer	0.00365	0.00423	CcSEcCtD
Ceftibuten—Dyspnoea—Hydroxyurea—brain cancer	0.00358	0.00414	CcSEcCtD
Ceftibuten—Somnolence—Hydroxyurea—brain cancer	0.00357	0.00413	CcSEcCtD
Ceftibuten—Diarrhoea—Procarbazine—brain cancer	0.00355	0.00411	CcSEcCtD
Ceftibuten—Dyspepsia—Hydroxyurea—brain cancer	0.00353	0.00409	CcSEcCtD
Ceftibuten—Agitation—Temozolomide—brain cancer	0.00353	0.00409	CcSEcCtD
Ceftibuten—SLC15A2—central nervous system—brain cancer	0.00352	0.0257	CbGeAlD
Ceftibuten—Decreased appetite—Hydroxyurea—brain cancer	0.00349	0.00404	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00346	0.00401	CcSEcCtD
Ceftibuten—Fatigue—Hydroxyurea—brain cancer	0.00346	0.00401	CcSEcCtD
Ceftibuten—SLC15A2—cerebellum—brain cancer	0.00345	0.0252	CbGeAlD
Ceftibuten—Convulsion—Carmustine—brain cancer	0.00344	0.00399	CcSEcCtD
Ceftibuten—Constipation—Hydroxyurea—brain cancer	0.00343	0.00397	CcSEcCtD
Ceftibuten—Dizziness—Procarbazine—brain cancer	0.00343	0.00397	CcSEcCtD
Ceftibuten—Erythema multiforme—Etoposide—brain cancer	0.00334	0.00387	CcSEcCtD
Ceftibuten—Convulsion—Temozolomide—brain cancer	0.00333	0.00385	CcSEcCtD
Ceftibuten—Vomiting—Procarbazine—brain cancer	0.00329	0.00382	CcSEcCtD
Ceftibuten—Rash—Procarbazine—brain cancer	0.00327	0.00379	CcSEcCtD
Ceftibuten—Dermatitis—Procarbazine—brain cancer	0.00326	0.00378	CcSEcCtD
Ceftibuten—Headache—Procarbazine—brain cancer	0.00325	0.00376	CcSEcCtD
Ceftibuten—Dry mouth—Temozolomide—brain cancer	0.0032	0.0037	CcSEcCtD
Ceftibuten—Body temperature increased—Hydroxyurea—brain cancer	0.00317	0.00367	CcSEcCtD
Ceftibuten—Chills—Etoposide—brain cancer	0.00317	0.00367	CcSEcCtD
Ceftibuten—Anaphylactic shock—Temozolomide—brain cancer	0.00313	0.00363	CcSEcCtD
Ceftibuten—Anorexia—Carmustine—brain cancer	0.00309	0.00358	CcSEcCtD
Ceftibuten—Nausea—Procarbazine—brain cancer	0.00308	0.00357	CcSEcCtD
Ceftibuten—Dysgeusia—Etoposide—brain cancer	0.00301	0.00349	CcSEcCtD
Ceftibuten—Anorexia—Temozolomide—brain cancer	0.00299	0.00346	CcSEcCtD
Ceftibuten—Hypersensitivity—Hydroxyurea—brain cancer	0.00295	0.00342	CcSEcCtD
Ceftibuten—Insomnia—Carmustine—brain cancer	0.00293	0.0034	CcSEcCtD
Ceftibuten—Paraesthesia—Carmustine—brain cancer	0.00291	0.00337	CcSEcCtD
Ceftibuten—Dyspnoea—Carmustine—brain cancer	0.00289	0.00335	CcSEcCtD
Ceftibuten—Somnolence—Carmustine—brain cancer	0.00288	0.00334	CcSEcCtD
Ceftibuten—Asthenia—Hydroxyurea—brain cancer	0.00288	0.00333	CcSEcCtD
Ceftibuten—Insomnia—Temozolomide—brain cancer	0.00283	0.00328	CcSEcCtD
Ceftibuten—Decreased appetite—Carmustine—brain cancer	0.00282	0.00327	CcSEcCtD
Ceftibuten—Paraesthesia—Temozolomide—brain cancer	0.00281	0.00326	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Carmustine—brain cancer	0.0028	0.00324	CcSEcCtD
Ceftibuten—SLC15A2—brain—brain cancer	0.0028	0.0204	CbGeAlD
Ceftibuten—Dyspnoea—Temozolomide—brain cancer	0.00279	0.00324	CcSEcCtD
Ceftibuten—Somnolence—Temozolomide—brain cancer	0.00279	0.00323	CcSEcCtD
Ceftibuten—Constipation—Carmustine—brain cancer	0.00277	0.00321	CcSEcCtD
Ceftibuten—Dyspepsia—Temozolomide—brain cancer	0.00276	0.0032	CcSEcCtD
Ceftibuten—Diarrhoea—Hydroxyurea—brain cancer	0.00274	0.00318	CcSEcCtD
Ceftibuten—Decreased appetite—Temozolomide—brain cancer	0.00272	0.00316	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Temozolomide—brain cancer	0.0027	0.00313	CcSEcCtD
Ceftibuten—Fatigue—Temozolomide—brain cancer	0.0027	0.00313	CcSEcCtD
Ceftibuten—Constipation—Temozolomide—brain cancer	0.00268	0.0031	CcSEcCtD
Ceftibuten—Convulsion—Etoposide—brain cancer	0.00266	0.00308	CcSEcCtD
Ceftibuten—Dizziness—Hydroxyurea—brain cancer	0.00265	0.00307	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Carmustine—brain cancer	0.00265	0.00307	CcSEcCtD
Ceftibuten—Abdominal pain—Carmustine—brain cancer	0.00256	0.00297	CcSEcCtD
Ceftibuten—Body temperature increased—Carmustine—brain cancer	0.00256	0.00297	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Temozolomide—brain cancer	0.00256	0.00297	CcSEcCtD
Ceftibuten—Vomiting—Hydroxyurea—brain cancer	0.00255	0.00295	CcSEcCtD
Ceftibuten—Rash—Hydroxyurea—brain cancer	0.00253	0.00293	CcSEcCtD
Ceftibuten—Dermatitis—Hydroxyurea—brain cancer	0.00253	0.00293	CcSEcCtD
Ceftibuten—Headache—Hydroxyurea—brain cancer	0.00251	0.00291	CcSEcCtD
Ceftibuten—Anaphylactic shock—Etoposide—brain cancer	0.00251	0.0029	CcSEcCtD
Ceftibuten—Urticaria—Temozolomide—brain cancer	0.00249	0.00288	CcSEcCtD
Ceftibuten—Body temperature increased—Temozolomide—brain cancer	0.00248	0.00287	CcSEcCtD
Ceftibuten—Abdominal pain—Temozolomide—brain cancer	0.00248	0.00287	CcSEcCtD
Ceftibuten—Anorexia—Etoposide—brain cancer	0.00239	0.00277	CcSEcCtD
Ceftibuten—Hypersensitivity—Carmustine—brain cancer	0.00239	0.00277	CcSEcCtD
Ceftibuten—Nausea—Hydroxyurea—brain cancer	0.00238	0.00276	CcSEcCtD
Ceftibuten—Asthenia—Carmustine—brain cancer	0.00233	0.00269	CcSEcCtD
Ceftibuten—Hypersensitivity—Temozolomide—brain cancer	0.00231	0.00267	CcSEcCtD
Ceftibuten—Paraesthesia—Etoposide—brain cancer	0.00225	0.00261	CcSEcCtD
Ceftibuten—Asthenia—Temozolomide—brain cancer	0.00225	0.0026	CcSEcCtD
Ceftibuten—Dyspnoea—Etoposide—brain cancer	0.00224	0.00259	CcSEcCtD
Ceftibuten—Somnolence—Etoposide—brain cancer	0.00223	0.00258	CcSEcCtD
Ceftibuten—Diarrhoea—Carmustine—brain cancer	0.00222	0.00257	CcSEcCtD
Ceftibuten—Pruritus—Temozolomide—brain cancer	0.00222	0.00257	CcSEcCtD
Ceftibuten—Decreased appetite—Etoposide—brain cancer	0.00218	0.00252	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Etoposide—brain cancer	0.00216	0.00251	CcSEcCtD
Ceftibuten—Fatigue—Etoposide—brain cancer	0.00216	0.0025	CcSEcCtD
Ceftibuten—Dizziness—Carmustine—brain cancer	0.00214	0.00248	CcSEcCtD
Ceftibuten—Constipation—Etoposide—brain cancer	0.00214	0.00248	CcSEcCtD
Ceftibuten—Diarrhoea—Temozolomide—brain cancer	0.00214	0.00248	CcSEcCtD
Ceftibuten—Dizziness—Temozolomide—brain cancer	0.00207	0.0024	CcSEcCtD
Ceftibuten—Vomiting—Carmustine—brain cancer	0.00206	0.00239	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Etoposide—brain cancer	0.00205	0.00238	CcSEcCtD
Ceftibuten—Rash—Carmustine—brain cancer	0.00204	0.00237	CcSEcCtD
Ceftibuten—Dermatitis—Carmustine—brain cancer	0.00204	0.00237	CcSEcCtD
Ceftibuten—Headache—Carmustine—brain cancer	0.00203	0.00235	CcSEcCtD
Ceftibuten—Vomiting—Temozolomide—brain cancer	0.00199	0.00231	CcSEcCtD
Ceftibuten—Urticaria—Etoposide—brain cancer	0.00199	0.00231	CcSEcCtD
Ceftibuten—Body temperature increased—Etoposide—brain cancer	0.00198	0.0023	CcSEcCtD
Ceftibuten—Abdominal pain—Etoposide—brain cancer	0.00198	0.0023	CcSEcCtD
Ceftibuten—Rash—Temozolomide—brain cancer	0.00198	0.00229	CcSEcCtD
Ceftibuten—Dermatitis—Temozolomide—brain cancer	0.00197	0.00229	CcSEcCtD
Ceftibuten—Headache—Temozolomide—brain cancer	0.00196	0.00227	CcSEcCtD
Ceftibuten—Nausea—Carmustine—brain cancer	0.00193	0.00223	CcSEcCtD
Ceftibuten—Nausea—Temozolomide—brain cancer	0.00186	0.00216	CcSEcCtD
Ceftibuten—Hypersensitivity—Etoposide—brain cancer	0.00185	0.00214	CcSEcCtD
Ceftibuten—Asthenia—Etoposide—brain cancer	0.0018	0.00208	CcSEcCtD
Ceftibuten—Pruritus—Etoposide—brain cancer	0.00177	0.00206	CcSEcCtD
Ceftibuten—Diarrhoea—Etoposide—brain cancer	0.00172	0.00199	CcSEcCtD
Ceftibuten—Dizziness—Etoposide—brain cancer	0.00166	0.00192	CcSEcCtD
Ceftibuten—Vomiting—Etoposide—brain cancer	0.00159	0.00185	CcSEcCtD
Ceftibuten—Rash—Etoposide—brain cancer	0.00158	0.00183	CcSEcCtD
Ceftibuten—Dermatitis—Etoposide—brain cancer	0.00158	0.00183	CcSEcCtD
Ceftibuten—Headache—Etoposide—brain cancer	0.00157	0.00182	CcSEcCtD
Ceftibuten—Nausea—Etoposide—brain cancer	0.00149	0.00173	CcSEcCtD
